4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.
作者信息
Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, Harbeck N, Aguilar Lopez B, Barrios C H, Bergh J, Biganzoli L, Boers-Doets C B, Cardoso M J, Carey L A, Cortés J, Curigliano G, Diéras V, El Saghir N S, Eniu A, Fallowfield L, Francis P A, Gelmon K, Johnston S R D, Kaufman B, Koppikar S, Krop I E, Mayer M, Nakigudde G, Offersen B V, Ohno S, Pagani O, Paluch-Shimon S, Penault-Llorca F, Prat A, Rugo H S, Sledge G W, Spence D, Thomssen C, Vorobiof D A, Xu B, Norton L, Winer E P
机构信息
European School of Oncology (ESO), European Society for Medical Oncology (ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
European Society for Medical Oncology (ESMO) and Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
出版信息
Ann Oncol. 2018 Aug 1;29(8):1634-1657. doi: 10.1093/annonc/mdy192.
Abstract
摘要
相似文献
1
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.《第四届欧洲中学教育阶段（ESO）-欧洲肿瘤内科学会（ESMO）晚期乳腺癌国际共识指南（ABC 4）》† 。
Ann Oncol. 2018 Aug 1;29(8):1634-1657. doi: 10.1093/annonc/mdy192.
2
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.ESMO 睾丸生殖细胞癌共识会议：诊断、治疗和随访。
Ann Oncol. 2018 Aug 1;29(8):1658-1686. doi: 10.1093/annonc/mdy217.
3
The era of meta-analyses-based recommendations: how were the Japanese Breast Cancer Society Clinical Practice Guidelines for Systemic Treatment of Breast Cancer established?基于荟萃分析的推荐时代：日本乳腺癌学会乳腺癌全身治疗临床实践指南是如何制定的？
Breast Cancer. 2020 May;27(3):332-333. doi: 10.1007/s12282-020-01099-8.
4
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).ESO-ESMO 第 3 版年轻女性乳腺癌国际共识指南（BCY3）。
Breast. 2017 Oct;35:203-217. doi: 10.1016/j.breast.2017.07.017. Epub 2017 Aug 17.
5
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer.乳腺癌治疗专家组（BCTEG）圆桌讨论：人表皮生长因子受体2（HER2）阳性乳腺癌的临床进展与实践指南
Clin Breast Cancer. 2020 Jun;20(3):e251-e260. doi: 10.1016/j.clbc.2019.08.001. Epub 2019 Aug 21.
6
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.软组织和内脏肉瘤：ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv51-iv67. doi: 10.1093/annonc/mdy096.
7
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.骨肉瘤：ESMO-儿童癌症-欧洲骨肉瘤协作组诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-iv95. doi: 10.1093/annonc/mdy310.
8
A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.一项关于乳腺癌新辅助化疗反应的临床病理评估研究。
J Cancer Res Ther. 2020 Oct-Dec;16(6):1419-1425. doi: 10.4103/jcrt.JCRT_295_19.
9
Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference.肝移植治疗胆管细胞癌和混合型肝细胞胆管细胞癌：ILTS 移植肿瘤学共识会议工作组报告。
Transplantation. 2020 Jun;104(6):1125-1130. doi: 10.1097/TP.0000000000003212.
10
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.早期乳腺癌：ESMO 诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 Aug 1;30(8):1194-1220. doi: 10.1093/annonc/mdz173.
引用本文的文献
1
The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE study.EMBRACE研究中转移性乳腺癌诊断时的年轻年龄与总生存期之间的关联。
NPJ Breast Cancer. 2025 Aug 29;11(1):96. doi: 10.1038/s41523-025-00822-y.
2
Comparative long-term outcomes of first-line CDK4/6 inhibitors plus endocrine therapy versus endocrine therapy in patients with HR+/HER2-metastatic or advanced breast cancer: a meta-analysis.一线CDK4/6抑制剂联合内分泌治疗与内分泌治疗用于HR+/HER2-转移性或晚期乳腺癌患者的比较长期结局：一项荟萃分析。
Front Pharmacol. 2025 Jul 25;16:1600892. doi: 10.3389/fphar.2025.1600892. eCollection 2025.
3
Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot study.新辅助立体定向体部放射治疗联合达尔西利和依西美坦治疗激素受体阳性、人表皮生长因子受体2阴性乳腺癌的疗效和安全性：一项前瞻性试点研究。
Elife. 2025 Jul 28;14:RP101583. doi: 10.7554/eLife.101583.
4
A real-world study of palbociclib plus endocrine therapy with or without a short course chemotherapy in the first-line treatment of HR-positive HER2-negative metastatic breast cancer.一项关于哌柏西利联合内分泌治疗加或不加短期化疗用于HR阳性HER2阴性转移性乳腺癌一线治疗的真实世界研究。
Front Oncol. 2025 Jul 9;15:1512496. doi: 10.3389/fonc.2025.1512496. eCollection 2025.
5
Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence.通过传统光学显微镜、数字病理学和人工智能评估47例晚期乳腺癌粗针活检、匹配手术标本及其远处转移灶中HER2低表达和HER2超低表达状态的变化。
Breast Cancer Res Treat. 2025 Jul 22. doi: 10.1007/s10549-025-07776-6.
6
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapy.转移性HR+/HER2-乳腺癌患者在内分泌及CDK4/6抑制剂治疗期间的个性化循环肿瘤DNA监测
NPJ Breast Cancer. 2025 Jul 19;11(1):74. doi: 10.1038/s41523-025-00783-2.
7
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HRHER2 breast cancer via CX3CR1 macrophages.分泌白细胞介素-17A的γδ T细胞通过CX3CR1巨噬细胞促进HRHER2乳腺癌对细胞周期蛋白依赖性激酶4/细胞周期蛋白依赖性激酶6抑制剂的抗性。
Nat Cancer. 2025 Jul 7. doi: 10.1038/s43018-025-01007-z.
8
Circulating chemokines and leukocytes and their impact on breast cancer prognosis.循环趋化因子和白细胞及其对乳腺癌预后的影响。
Discov Oncol. 2025 Jun 11;16(1):1060. doi: 10.1007/s12672-025-02881-w.
9
Inflammatory breast cancer, best practice in the community setting.炎性乳腺癌，社区环境中的最佳实践。
NPJ Breast Cancer. 2025 Jun 7;11(1):52. doi: 10.1038/s41523-025-00765-4.
10
Options for postoperative radiation therapy in patients with de novo metastatic breast cancer.初发性转移性乳腺癌患者术后放射治疗的选择。
Breast. 2025 Aug;82:104483. doi: 10.1016/j.breast.2025.104483. Epub 2025 Apr 23.
本文引用的文献
1
Global analysis of advanced/metastatic breast cancer: Decade report (2005-2015).全球晚期/转移性乳腺癌分析：十年报告（2005-2015 年）。
Breast. 2018 Jun;39:131-138. doi: 10.1016/j.breast.2018.03.002. Epub 2018 Apr 19.
2
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.依维莫司联合内分泌治疗用于雌激素受体阳性、人表皮生长因子受体 2 阴性的绝经后晚期乳腺癌：一项临床试验。
JAMA Oncol. 2018 Jul 1;4(7):977-984. doi: 10.1001/jamaoncol.2018.0060.
3
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.恩杂鲁胺治疗雄激素受体表达的三阴性乳腺癌。
J Clin Oncol. 2018 Mar 20;36(9):884-890. doi: 10.1200/JCO.2016.71.3495. Epub 2018 Jan 26.
4
Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer.症状管理：聚乙二醇脂质体阿霉素引起的卵巢癌手足综合征的区域冷却的效用。
Support Care Cancer. 2018 Jul;26(7):2161-2166. doi: 10.1007/s00520-018-4054-z. Epub 2018 Jan 25.
5
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial.帕博西尼联合来曲唑对患者报告的健康相关生活质量的影响：来自 PALOMA-2 试验的结果。
Ann Oncol. 2018 Apr 1;29(4):888-894. doi: 10.1093/annonc/mdy012.
6
A Comprehensive Definition for Integrative Oncology.整合肿瘤学的全面定义。
J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52). doi: 10.1093/jncimonographs/lgx012.
7
Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.随时间推移的新发转移性乳腺癌与复发性转移性乳腺癌的差异表现与生存：1990-2010 年。
Breast Cancer Res Treat. 2018 Jan;167(2):579-590. doi: 10.1007/s10549-017-4529-5. Epub 2017 Oct 16.
8
ESMO-Magnitude of Clinical Benefit Scale version 1.1.ESMO-临床获益量表 1.1 版
Ann Oncol. 2017 Oct 1;28(10):2340-2366. doi: 10.1093/annonc/mdx310.
9
Genetic testing in women with breast cancer: implications for treatment.乳腺癌女性的基因检测：对治疗的影响
Expert Rev Anticancer Ther. 2017 Nov;17(11):991-1002. doi: 10.1080/14737140.2017.1374175. Epub 2017 Sep 8.
10
Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers.生物类似药：欧洲医学肿瘤学会立场文件，特别涉及肿瘤学开方医生
ESMO Open. 2017 Jan 16;1(6):e000142. doi: 10.1136/esmoopen-2016-000142. eCollection 2016.
Zotero 插件